Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $2.8 million.

  • Firefly Neuroscience's Total Liabilities rose 848.13% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 848.13%. This contributed to the annual value of $5.0 million for FY2024, which is 9652.45% up from last year.
  • Per Firefly Neuroscience's latest filing, its Total Liabilities stood at $2.8 million for Q3 2025, which was up 848.13% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's Total Liabilities peaked at $7.2 million during Q1 2025, and registered a low of $1.9 million during Q2 2024.
  • In the last 5 years, Firefly Neuroscience's Total Liabilities had a median value of $3.8 million in 2021 and averaged $3.8 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 5819.64% in 2024, then surged by 24909.0% in 2025.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Total Liabilities stood at $5.9 million in 2021, then decreased by 28.21% to $4.3 million in 2022, then plummeted by 40.44% to $2.5 million in 2023, then surged by 96.52% to $5.0 million in 2024, then crashed by 44.73% to $2.8 million in 2025.
  • Its Total Liabilities stands at $2.8 million for Q3 2025, versus $2.8 million for Q2 2025 and $7.2 million for Q1 2025.